At the 2023 World Congress on Gastrointestinal Cancers, Anna Wagner, MD, discusses the addition of trastuzumab to perioperative chemotherapy for patients with HER2-positive gastric or gastroesophageal junction cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Anna Wagner, MD, discusses the addition of trastuzumab to perioperative chemotherapy for patients with HER2-positive gastric or gastroesophageal junction cancer.
At the 2023 World Congress on...